GigaMune is a San Francisco biotechnology company developing a pipeline of in vivo cell therapies for cancer and inherited blood disorders, utilizing viral gene delivery vectors to overcome manufacturing bottlenecks
GigaMune is a San Francisco biotechnology company developing a pipeline of in vivo cell therapies for cancer and inherited blood disorders, utilizing viral gene delivery vectors to overcome manufacturing bottlenecks.
GigaMune is a San Francisco biotechnology company developing a pipeline of in vivo cell therapies for cancer and inherited blood disorders, utilizing viral gene delivery vectors to overcome manufacturing bottlenecks
GigaMune is a San Francisco biotechnology company developing a pipeline of in vivo cell therapies for cancer and inherited blood disorders, utilizing viral gene delivery vectors to overcome manufacturing bottlenecks.